C12N 2770/40011
Tymoviridae
C12N2770/40011 (Tymoviridae) appears on 31 US grants and 37 published applications in this corpus.
Search patents in C12N- Granted patents
- 31
- Published applications
- 37
- Assignees
- 31
- Inventors
- 127
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 2 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 2 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 3 |
| 2014 | 1 | 1 |
| 2015 | 1 | 3 |
| 2016 | 1 | 2 |
| 2017 | 2 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 2 |
| 2020 | 2 | 4 |
| 2021 | 0 | 1 |
| 2022 | 2 | 2 |
| 2023 | 4 | 2 |
| 2024 | 3 | 5 |
| 2025 | 1 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2770/40022New viral proteins or individual genes, new structural or functional aspects ofIndexing code14
- C12N 2770/40023Virus like particles [vlp]Indexing code8
- C12N 2770/40051Methods of production or purification of viral materialIndexing code7
- C12N 2770/40061Methods of inactivation or attenuationIndexing code4
- C12N 2770/40034Use of virus or viral component as vaccineIndexing code3
- C12N 2770/40041Use of virus, viral particle or viral elements as a vectorIndexing code3
- C12N 2770/40031Uses of virus other than therapeutic or vaccineIndexing code2
- C12N 2770/40032Use of virus as therapeutic agent, other than vaccineIndexing code2
Recent patents
- Tymovirus virus and virus-like particles as nanocarriers for imaging and therapeutic agents21 Apr 2026US 12,606,805 B2Case Western Reserve University
- Anticancer trail-targeted plant virus particles18 Mar 2025US 12,251,410 B2Case Western Reserve University
- Virus and antigen conjugation24 Dec 2024US 12,173,328 B2Kbio Holdings Limited
- Virus and antigen purification and conjugation24 Sep 2024US 12,097,256 B2Kbio Holdings Limited
- Cancer immunotherapy using virus particles27 Aug 2024US 12,070,478 B2Case Western Reserve University
- Artificial tymovirales satellite rnas1 Oct 2026US 2026/0297606 A1Flagship Pioneering Innovations Vii, LLC
- Modified plant virus system for delivery of nucleic acids into mammalian cells30 Oct 2025US 2025/0332284 A1
- Cancer immunotherapy using virus particles13 Feb 2025US 2025/0049866 A1
- Viral coat delivery of insect resistance genes in plants31 Oct 2024US 2024/0360468 A1BASF Agricultural Solutions Seed US LLC
- Virus and antigen purification and conjugation26 Sep 2024US 2024/0316188 A1Kbio Holdings Limited
Most cited
By later US patents
- Virus-resistant plants28US 4,970,168 AMonsanto Company · 1990
- Binary viral expression system in plants21US 6,632,980 B1E. I. Du Pont de Nemours and Company · 2003
- Virus resistant plants18US 5,185,253 AMonsanto Company · 1993
- Virus-resistant transgenic plants6US 5,576,202 AHelsinki University Licensing, Ltd. · 1996
- Methods for regulated expression of triats in plants using multiple site-specific recombination systems6US 7,115,798 B1E. I. Du Pont de Nemours and Company · 2006